VERIGENE Clostridium difficile Nucleic Acid Test, REF 30-002-022 — FDA record Z-2024-2023

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jun 5, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
VERIGENE Clostridium difficile Nucleic Acid Test, REF 30-002-022
Reason
It is possible that in rare instances the VERIGENE CDF Nucleic Acid Test Kit (Part No. 20-005-022) and the VERIGENE Enteric Pathogens Nucleic Acid Test Kit (Part No. 20-005-023) could provide a false-negative result due to hydrophobic characteristics in specific FLOQSwab lots.
Classification
Class II
Recalling firm
Luminex Corporation
Quantity
114 units
Agency-reported status
Ongoing
Source record identifier
Z-2024-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI/DI , Lot Numbers: 071222022D, 100622022D

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Worldwide and US Nationwide Distribution

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Jul 5, 2023
Recall initiation date
Jun 5, 2023
Center classification date
Jun 28, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records